A detailed history of Slow Capital, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Slow Capital, Inc. holds 16,226 shares of RGEN stock, worth $2.08 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
16,226
Previous 16,165 0.38%
Holding current value
$2.08 Million
Previous $2.04 Million 18.51%
% of portfolio
0.37%
Previous 0.33%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.79 - $167.35 $7,307 - $10,208
61 Added 0.38%
16,226 $2.41 Million
Q2 2024

Jul 24, 2024

BUY
$120.0 - $182.95 $186,960 - $285,036
1,558 Added 10.67%
16,165 $2.04 Million
Q1 2024

Apr 17, 2024

BUY
$170.78 - $208.42 $59,431 - $72,530
348 Added 2.44%
14,607 $2.69 Million
Q4 2023

Jan 30, 2024

BUY
$114.17 - $185.35 $30,483 - $49,488
267 Added 1.91%
14,259 $2.56 Million
Q3 2023

Oct 19, 2023

BUY
$138.78 - $176.51 $308,507 - $392,381
2,223 Added 18.89%
13,992 $2.22 Million
Q2 2023

Aug 09, 2023

SELL
$138.42 - $180.31 $46,785 - $60,944
-338 Reduced 2.79%
11,769 $1.66 Million
Q1 2023

Apr 26, 2023

BUY
$154.26 - $198.1 $55,842 - $71,712
362 Added 3.08%
12,107 $2.04 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $119,378 - $162,111
735 Added 6.68%
11,745 $1.99 Million
Q3 2022

Oct 27, 2022

BUY
$160.42 - $256.21 $1,283 - $2,049
8 Added 0.07%
11,010 $2.06 Million
Q2 2022

Jul 28, 2022

BUY
$140.68 - $188.02 $1.55 Million - $2.07 Million
11,002 New
11,002 $1.79 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.13B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Slow Capital, Inc. Portfolio

Follow Slow Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.